Publications
5674 Results
- Journal / Conference
- J Clin Oncol 37(suppl 27; abstr 119); ASCO Quality of Care Symposium (Sept 6-7, 2019, San Diego, CA), accepted, oral
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
Patients enrolled in clinical trials with Medicaid or no insurance have reduced overall survival benefits from new interventions
- Journal / Conference
- J Clin Oncol 37 (suppl 27; abstr 162); ASCO Quality of Care Symposium (Sept 6-7, 2019, San Diego, CA), poster
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
Socioeconomic deprivation and cancer outcomes in patients treated in clinical trials
- Journal / Conference
- Journal of Clinical Oncology Oct 1;37(28):2537-2547; Aug 6:JCO1900269. doi: 10.1200/JCO.19.00269. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID31386610
- PMC
- PMC7001793
- Study Number(s)
- S0905
Phase II Trial of Cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905)
- Journal / Conference
- ASCO GU Cancers Symposium (Feb 14-16, 2019, San Francisco, CA), poster
- Year
- 2019
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8143
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143)
- Journal / Conference
- Leukemia Nov;33(11):2599-2609
- Year
- 2019
- Research Committee(s)
- Leukemia
- PMID
- PMID31073153
- PMC
- PMC6842042
- Study Number(s)
- S0432, S0703
Allogeneic Hematopoietic Cell Transplantation Compared to Chemotherapy Consolidation in older Acute Myeloid Leukemia (AML) Patients 60-75 Years in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study
- Journal / Conference
- WCLC IASCLC Annual Meeting (September 7-10, 2019, Barcelona, Spain), accepted, mini-oral presentation
- Year
- 2019
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/E1505
E1505: Adjuvant Chemotherapy +/- Bevacizumab for early stage NSCLC: Updated chemotherapy subset analysis
- Journal / Conference
- WCLC IASCLC Annual Meeting (September 7-10, 2019, Barcelona, Spain), oral
- Year
- 2019
- Research Committee(s)
- Lung
- Study Number(s)
- S1400I
A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Lung Cancer
- Journal / Conference
- New England Journal of Medicine Aug 1;381(5):432-443
- Year
- 2019
- Research Committee(s)
- Leukemia
- PMID
- PMID31365801
- PMC
- PMC6908306
- Study Number(s)
- CTSU/E1912
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
- Journal / Conference
- Journal of Urology Vol. 201, No. 4S, Supplement, abst MP14-18, poster (American Urological Association Annual Meeting,May 3-6, 2019, Chicago, IL)
- Year
- 2019
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E2805
An Anatomic Classification System for Local Recurrence Following Resection of Intermediate and High Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Trial
- Journal / Conference
- American Urological Association Annual Meeting (May 3-6, 2019, Chicago, IL), poster
- Year
- 2019
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/C90203